Clinical Trials Browser

Recurrence, Endometrial Neoplasms

Adenocarcinoma of Endometrium

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms

Neoplasm Metastasis, Sarcoma, Ewing

Ovarian Neoplasms

Endometrial Neoplasms

Malignant Neoplasms of Female Genital Organs

Breast Neoplasms, Neoplasm, Residual

Breast Neoplasms

Brain Neoplasms, Neoplasm Metastasis

Liver Metastases From Colorectal Cancer (mCRC)

Anatomic Stage III Breast Cancer AJCC v8

Prostatic Neoplasms

Breast Neoplasms

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms

Endometrial Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms

ER-Positive Breast Cancer

Neoplasm Metastasis

Breast Neoplasms

Gastro-enteropancreatic neuroendocrine tumor, Adenoma, Islet Cell

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms, Squamous Cell

Breast Neoplasms

Breast Neoplasms, Male

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

Clinical Trials

A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer

Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer

I-SPY

Abemaciclib in Newly Diagnosed Meningioma Patients

CARABELA

CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma

BOUQUET

Abemaciclib and Letrozole to Treat Endometrial Cancer

Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma

MiRaDoR

VIOLET

Genetic Testing in Guiding Treatment for Patients With Brain Metastases

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Abemaciclib With or Without Atezolizumab for mCRPC

Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Breast Cancer

TAPUR

ALPINE: Maintenance Letrozole/Abemaciclib

EVOLVE-BDT

Next MONARCH 1

Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer

GERTRUDE

TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer

Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors

Immune Modulation by Abemaciclib in Head and Neck Squamous Cell Carcinoma (HNSCC). (AIM Trial)

Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer

ETHAN - ET for Male BC

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer